1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 409-416

  Lo Vasco, Vincenza Rita ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

1p36; Chordoma; Neuroblastoma; Oligodendroglioma; Phospholipase C 2

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; PHOSPHATIDYLINOSITIDE; PHOSPHOINOSITIDE SPECIFIC PHOSPHOLIPASE C ETA2; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ASTROCYTOMA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER SURVIVAL; CHORDOMA; CHROMOSOME 1P; CHROMOSOME 1P36; CHROMOSOME 1P36 DELETION SYNDROME; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; HETEROZYGOSITY LOSS; HUMAN; NERVE CELL NETWORK; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; NONHUMAN; OLIGODENDROGLIOMA; POSTNATAL DEVELOPMENT; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 85027953297     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0422-3     Document Type: Review

References (53)

1. Lahortiga I, Vázquez I, Belloni E, Román JP, Gasparini P, Novo FJ, Zudaire I, Pelicci PG, Hernández JM, Calasanz MJ, Odero MD (2005) FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome. Hum Genet 116(6):476-485 (Pubitemid 41166778)
2. Brown WM, Lange EM, Chen H, Zheng SL, Chang B, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cooney KA (2004) Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci. Br J Cancer 90(2):510-514
3. Nishimura T, Nishida N, Itoh T, Komeda T, Fukuda Y, Ikai I, Yamaoka Y, Nakao K (2005) Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis. Genes Chromosomes Cancer 42(1):34-43 (Pubitemid 39578663)
4. Yanada M, Yaoi T, Shimada J, Sakakura C, Nishimura M, Ito K, Terauchi K, Nishiyama K, Itoh K, Fushiki S (2005) Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol Rep 14(4):817-822
5. Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD (2008) Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ann Surg Oncol 15(9):2519-2525
6. Zhang S, Wei L, Zhang A, Zhang L, Yu H (2009) RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines. OMICS 13(4):307-311
7. Poetsch M, Dittberner T, Woenckhaus C (2003) Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region. Melanoma Res 13(1):29-33 (Pubitemid 36269811)
8. Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS, Ahn WS (2007) Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 17(3):687-696 (Pubitemid 46743999)
9. Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL, Maris JM (2005) High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43(4):390-403 (Pubitemid 40946474)
10. Pfisterer WK, Hank NC, Preul MC, Hendricks WP, Pueschel J, Coons SW, Scheck AC (2004) Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro Oncol 6(4):290-299 (Pubitemid 39429832)
11. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB (2005) Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosome Cancer 42(1):68-77 (Pubitemid 39582821)
12. Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C (2005) Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. Int J Oncol 26(5): 1385-1391
13. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH (2004) Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4:45
14. Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC (2009) Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization. (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol 2:47
15. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 86(10): 3753-3757
16. Wu YQ, Heilstedt HA, Bedell JA, May KM, Starkey DE, McPherson JD, Shapira SK, Shaffer LG (1999) Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 8(2):313-321 (Pubitemid 29054273)
17. Ballif BC, Kashork CD, Shaffer LG (2000) FISHing for mechanisms of cytogenetically defined terminal deletions using chromosome-specific subtelomeric probes. Eur J Hum Genet 8(10):764-770
18. Ballif BC, Gajecka M, Shaffer LG (2004) Monosomy 1p36 breakpoints indicate repetitive DNA sequence elements may be involved in generating and/or stabilizing some terminal deletions. Chromosome Res 12(2):133-141 (Pubitemid 38316590)
19. Gajecka M, Yu W, Ballif BC, Glotzbach CD, Bailey KA, Shaw CA, Kashork CD, Heilstedt HA, Ansel DA, Theisen A, Rice R, Rice DP, Shaffer LG (2005) Delineation of mechanisms and regions of dosage imbalance in complex rearrangements of 1p36 leads to a putative gene for regulation of cranial suture closure. Eur J Hum Genet 13(2):139-149 (Pubitemid 40220556)
20. Gajecka M, Pavlicek A, Glotzbach CD, Ballif BC, Jarmuz M, Jurka J, Shaffer LG (2006) Identification of sequence motifs at the breakpoint junctions in three t(1;9)(p36.3;q34) and delineation of mechanisms involved in generating balanced translocations. Hum Genet 120(4):519-526 (Pubitemid 44669785)
21. Chen Z, Grebe TA, Guan XY, Notohamiprodjo M, Nutting PJ, Stone JF, Trent JM, Sandberg AA (2007) Maternal balanced translocation leading to partial duplication of 4q and partial deletion of 1p in a son: cytogenetic and FISH studies using band-specific painting probes generated by chromosome microdissection. Am J Med Genet 71:160-166
22. Biegel JA, White PS, Marshall HN, Fujimori M, Zackai EH, Scher CD, Brodeur GM, Emanuel BS (1993) Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 52(1):176-182 (Pubitemid 23059061)
23. Isidor B, Le Cunff M, Boceno M, Boisseau P, Thomas C, Rival JM, David A, Le Caignec C (2008) Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma. Eur J Med Genet 51(6):679-684
24. Jeuken JW, Sprenger SH, Wesseling P, Macville MV, von Deimling A, Teepen HL, van Overbeeke JJ, Boerman RH (1999) Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 58(6):606-612 (Pubitemid 29264940)
25. Miozzo M, Dalprà L, Riva P, Volontà M, Macciardi F, Pericotti S, Tibiletti MG, Cerati M, Rohde K, Larizza L, Fuhrman Conti AM (2000) A tumor suppressor locus in familial and sporadic chordoma maps to 1p36. Int J Cancer 87(1):68-72 (Pubitemid 30368417)
26. Maris JM, Matthay KK (1999) Molecular biology of neuroblastoma. J Clin Oncol 17(7):2264-2279 (Pubitemid 29318861)
27. Schmidt ML, Lal A, Dittmann D (2000) Differential expression in an antisense MYCN neuroblastoma model. Med Pediatr Oncol 35(6):669-672
28. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM (1999) Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18(35):4948-4957 (Pubitemid 29425301)
29. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334(4): 225-230 (Pubitemid 26030673)
30. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM (2005) Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24(16):2684-2694 (Pubitemid 40593096)
31. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2(5):245-255
32. Suh PG, Park J, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yuk S, Ryu SH (2008) Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Reports 41:415-434 (Pubitemid 351914885)
33. Nakamura Y, Fukami K (2009) Roles of phospholipase C isozymes in organogenesis and embryonic development. Physiology 24:332-341
34. Comer FI, Parent CA (2007) Phosphoinositides specify polarity during epithelial organ development. Cell 128(2):239-240 (Pubitemid 46127798)
35. Lo Vasco VR (2010) Signalling in the genomic era. J Cell Comm Signall. Epub 19 June
36. Hokin MR, Hokin LE (1953) Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. J Biol Chem 203(2):967-977
37. Irvine RF (2003) Nuclear lipid signalling. Nat Rev Mol Cell Biol 4:349-360
38. Cocco L, Capitani S, Maraldi NM, Mazzotti G, Barnabei O, Gilmour RS, Manzoli FA (1996) Inositol lipid cycle and autonomous nuclear signalling. Adv Enzyme Regul 36:101-114 (Pubitemid 27065707)
39. Hisatsune C, Nakamura K, Kuroda Y, Nakamura T, Mikoshiba K (2005) Amplification of Ca2 + signaling by diacylglycerol-mediated inositol 1, 4, 5-trisphosphate production. J Biol Chem 280(12):11723-11730 (Pubitemid 40418486)
40. Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa V, Martelli AM, Manzoli L (2009) Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. Adv Enzyme Regul 49(1):2-10
41. Lo Vasco VR, Fabrizi C, Artico M, Cocco L, Billi AM, Fumagalli L, Manzoli FA (2007) Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured astrocytes. J Cell Biochem 100:952-959
42. Lo Vasco VR, Fabrizi C, Fumagalli L, Cocco L (2010) Expression of phosphoinositide specific phospholipase C isoenzymes in cultured astrocytes activated after stimulation with Lipopolysaccharide. J Cell Biochem 109(5):1006-1012
43. Stewart AJ, Mukherjee J, Roberts SJ, Lester D, Farquharson C (2005) Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes. Int J Mol Med 15(1):117-121
44. Nakahara M, Shimozawa M, Nakamura Y, Irino Y, Morita M, Kudo Y, Fukami K (2005) A novel phospholipase C, PLC (eta)2, is a neuron-specific isozyme. J Biol Chem 280(32):29128-29134 (Pubitemid 41161363)
45. Katan M (2005) New insights into the families of PLC enzymes: looking back and going forward. Biochem J 391(Pt 3):e7-e9
46. Zhou Y, Wing MR, Sondek J, Harden TK (2005) Molecular cloning and characterization of PLC-eta-2. Biochem J 391:667-676
47. Kanemaru K, Nakahara M, Nakamura Y, Hashiguchi Y, Kouchi Z, Yamaguchi H, Oshima N, Kiyonari H, Fukami K (2010) Phospholipase C-eta2 is highly expressed in the habenula and retina. Gene Expr Patterns 10(2-3):119-126
48. Fukami K, Inanobe S, Kanemaru K, Nakamura Y (2010) Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog Lipid Res 49(4):429-437
49. Stewart AJ, Morgan K, Farquharson C, Millar RP (2007) Phospholipase C-eta enzymes as putative protein kinase C and Ca2 + signalling components in neuronal and neuroendocrine tissues. Neuroendocrinology 86(4):243-248 (Pubitemid 350136506)
50. Ha Y, Tsukada A, Saito N, Zadworny D, Shimada K (2008) Identification of differentially expressed genes involved in the regression and development of the chicken Müllerian duct. Int J Dev Biol 52(8):1135-1141
51. Blatt J (2001) Tumor suppressor genes on the short arm of chromosome 1 in neuroblastoma. Pediatr Hematol Oncol 18(1):3-5
52. Ejeskär K, Sjöberg RM, Kogner P, Martinsson T (1999) Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development. Int J Mol Med 3(6):585-589
53. Eggert A, Grotzer MA, Zuzak TJ, Ikegaki N, Zhao H, Brodeur GM (2002) Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system. Eur J Cancer 38(1):92-98 (Pubitemid 34031831)